BlackRock’s Enveric Biosciences ENVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $727 | Hold |
601
| – | – | ﹤0.01% | 5293 |
|
|
2025
Q1 | $835 | Hold |
601
| – | – | ﹤0.01% | 5290 |
|
|
2024
Q4 | $3.23K | Hold |
601
| – | – | ﹤0.01% | 5203 |
|
|
2024
Q3 | $4.27K | Sell |
601
-1,371
| -70% | -$9.74K | ﹤0.01% | 5003 |
|
|
2024
Q2 | $18.5K | Hold |
1,972
| – | – | ﹤0.01% | 4964 |
|
|
2024
Q1 | $29.6K | Hold |
1,972
| – | – | ﹤0.01% | 4910 |
|
|
2023
Q4 | $38.5K | Hold |
1,972
| – | – | ﹤0.01% | 4929 |
|
|
2023
Q3 | $70.4K | Hold |
1,972
| – | – | ﹤0.01% | 4864 |
|
|
2023
Q2 | $99.7K | Hold |
1,972
| – | – | ﹤0.01% | 4824 |
|
|
2023
Q1 | $49.2K | Hold |
1,972
| – | – | ﹤0.01% | 5037 |
|
|
2022
Q4 | $61.5K | Hold |
1,972
| – | – | ﹤0.01% | 5088 |
|
|
2022
Q3 | $125K | Buy |
1,972
+1,371
| +228% | +$86.9K | ﹤0.01% | 5016 |
|
|
2022
Q2 | $97K | Sell |
601
-64
| -10% | -$10.3K | ﹤0.01% | 5157 |
|
|
2022
Q1 | $165K | Sell |
665
-4
| -0.6% | -$992 | ﹤0.01% | 5067 |
|
|
2021
Q4 | $466K | Buy |
669
+2
| +0.3% | +$1.39K | ﹤0.01% | 4814 |
|
|
2021
Q3 | $1.04M | Sell |
667
-12
| -2% | -$18.6K | ﹤0.01% | 4476 |
|
|
2021
Q2 | $1.21M | Sell |
679
-72
| -10% | -$129K | ﹤0.01% | 4384 |
|
|
2021
Q1 | $1.73M | Buy |
+751
| New | +$1.73M | ﹤0.01% | 4265 |
|